Background Coronavirus disease 2019 (COVID-19) is associated with a high disease
burden with 10% of confirmed cases progressing towards critical illness. Nevertheless, the …

Due to marked heterogeneity of clinical presentations, comprehensive knowledge of angioedema
phenotypes is crucial for correct diagnosis and choosing the appropriate therapeutic …

… Author links open overlay panel Andrea Zanichelli MD a , Giulia Maria Azin MD a , Maddalena
Alessandra Wu MD a , Chiara Suffritti PhD a , Lorena Maggioni PhD a , Sonia Caccia PhD …

Marginal zone lymphoma represents about 10% of all non‐Hodgkin lymphomas ( NHL s). 33%
of patients with acquired angioedema ( AAE ) due to acquired C1‐inhibitor (C1‐ INH ) …

Several clinical and biological features of lymphoproliferative diseases have been associated
with an increased risk of developing autoimmune manifestations. Acquired deficiency of …

Background It remains elusive how the characteristics, the course of disease, the clinical
management and the outcomes of critically ill COVID-19 patients admitted to intensive care …

An impairment of the endothelial barrier function underlies a wide spectrum of pathological
conditions. Hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) can be …

Background Autoptic pulmonary findings have been described in severe COVID-19 patients,
but evidence regarding the correlation between clinical picture and lung histopathologic …

Background: Paroxysmal Permeability Disorders (PPDs) are pathological conditions caused
by periodic short lasting increase of endothelial permeability, in the absence of inflammatory…

Introduction: Hereditary angioedema (HAE) usually results from C1 inhibitor (C1-INH) deficiency
or dysfunction. It is a rare autosomal dominant disorder characterized by localized, non-…